title: Managing dyslipidemias: update on guidelines and pharmacotherapy.
abstract: New guidelines, the Adult Treatment Panel III (ATP III), for diagnosis and treatment of dyslipidemias are more stringent than older ones. Based on ATP III, 65 million Americans need therapeutic lifestyle changes, 36.5 million of whom require drug therapy. Guidelines do not work unless implemented--and therein lies an important role for pharmacists. Pharmacists in many different practice settings can screen patients for lipid disorders, assist in implementing treatment of high cholesterol levels, and maintain contact with patients with these chronic, common conditions.
authors.affiliation: Massachusetts College of Pharmacy and Health Sciences, Boston, USA.
authors.forename: Robert P
authors.initials: RP
authors.lastname: Paone
authors.forename: Marialice
authors.initials: M
authors.lastname: Bennett
mesh_terms: D000328:Adult; D003157:Community Pharmacy Services; D006801:Humans; D006949:Hyperlipidemias / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D012307:Risk Factors
chemical_list: D000960:Hypolipidemic Agents